Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (K23 DK087903-01A1)
Chicago Center for Diabetes Translation Research (NIDDK P30 DK092949)
National Institutes of Health (NIH CTSA UL1 TR000430)
Received: 2 May 2021
Accepted: 24 February 2022
First Online: 10 March 2022
: The University of Chicago Institutional Review Board approved all study procedures, and this study was registered at clinicaltrials.gov (NCT02347514). Staff and intervention patients provided written informed consent before participating in the study.
: Not applicable.
: Arshiya A. Baig, MD, MPH has no conflicts of interest to disclose.Erin M. Staab, MPH has no conflicts of interest to disclose.Amanda Benitez, MPH has no conflicts of interest to disclose.Sarah P. Hermans, MD, MPH has no conflicts of interest to disclose.Sandra A. Ham, MS has no conflicts of interest to disclose.Wen Wan, PhD has no conflicts of interest to disclose.Amanda Campbell, BA has no conflicts of interest to disclose.Cynthia T. Schaefer, RN, PhD has no conflicts of interest to disclose.Michael T. Quinn, PhD has no conflicts of interest to disclose.All authors have read and approved the manuscript.